Wits University Researchers Identify Distinct Saliva Microbiome Signatures Linked to Oesophageal Squamous Cell Carcinoma
In a significant advancement for cancer detection in South Africa, scientists at the University of the Witwatersrand have uncovered compelling evidence that bacteria present in saliva may serve as an early indicator for oesophageal squamous cell carcinoma, one of the country's most aggressive and understudied malignancies. The findings, detailed in a newly published study, suggest that microbial patterns in oral samples could one day support low-cost triage tools to identify individuals who would benefit from further investigation, potentially shifting outcomes in regions where late-stage diagnosis remains common.
The research stems from collaborative work at the Sydney Brenner Institute for Molecular Bioscience, where a team led by Dr Wenlong Carl Chen examined saliva samples from patients with confirmed oesophageal squamous cell carcinoma alongside healthy controls. By applying genetic sequencing techniques to map bacterial communities and machine-learning algorithms to interpret the data, the group identified clear differences in microbial composition. These differences allowed their predictive model to outperform approaches relying solely on demographic and clinical information.
Understanding Oesophageal Squamous Cell Carcinoma in the South African Context
Oesophageal squamous cell carcinoma differs markedly from the adenocarcinoma subtype more prevalent in many high-income countries. In South Africa the squamous cell form predominates and follows a distinctive geographic and demographic pattern, with elevated rates along the eastern seaboard, particularly in the Eastern Cape and KwaZulu-Natal provinces. Patients often present at a relatively young age, with an average of around 50 years and nearly one-fifth of cases occurring before age 40. This profile contrasts with typical expectations for many cancers and complicates efforts to pinpoint precise causes.
Known risk factors include tobacco use, heavy alcohol consumption, residence in rural areas, lower levels of formal education and exposure to biomass fuels for cooking and heating. Yet these elements do not account for the full burden of disease or its clustering in specific communities. Environmental, genetic and possibly microbial influences appear to interact in ways that researchers continue to unravel.
The Role of the Sydney Brenner Institute for Molecular Bioscience
The Sydney Brenner Institute for Molecular Bioscience stands at the forefront of molecular and genetic research in Africa. Its scientists combine advanced genomic tools with population-based studies to address health challenges unique to the continent. In this project the institute partnered with Columbia University in New York, bringing together expertise in microbiome analysis and cancer epidemiology.
Director Professor Michèle Ramsay emphasised that the current work lays essential groundwork for future clinical applications. The institute's ongoing commitment to community-engaged research ensures that findings can be translated into practical benefits for South African populations most affected by the disease.
Methods and Design of the Published Study
The investigation utilised 16S rRNA gene sequencing to characterise bacterial communities in saliva. This approach provides a detailed snapshot of microbial diversity without the need for culturing individual organisms. Researchers then trained machine-learning classifiers on the resulting data to distinguish between cancer cases and controls.
The model demonstrated strong performance even when tested internally, highlighting specific taxa such as Fusobacterium nucleatum that appeared enriched in patients with the malignancy. Importantly, the microbiome-based predictions surpassed those generated from standard risk-factor information alone, indicating that microbial signals capture additional, previously unrecognised information.
Key Findings from the Microbiome Analysis
Participants with oesophageal squamous cell carcinoma exhibited measurable shifts in their oral bacterial profiles compared with unaffected individuals. These shifts were consistent enough to support predictive modelling across the sampled groups. While the precise causal role of these bacteria remains under investigation, the patterns may reflect physiological changes in the oesophagus, such as partial obstruction or altered local environment, that occur gradually as disease develops.
Fusobacterium nucleatum, already associated with other gastrointestinal cancers, stood out as one of the more abundant species in the cancer group. Its presence aligns with broader scientific interest in how certain oral bacteria may influence or respond to tumour microenvironments elsewhere in the digestive tract.
Potential for Low-Cost Triage in High-Burden Communities
Endoscopy remains the gold-standard diagnostic procedure, yet access can be limited in resource-constrained settings. A saliva or even cheek-swab collection method would require minimal infrastructure and could be administered by community health workers. Positive microbial signals might then prompt timely referral for endoscopic confirmation, reducing the proportion of patients who arrive only when swallowing becomes severely impaired.
Such a tool would not replace existing diagnostic pathways but could function as an upstream filter, improving the efficiency of specialist services in provinces with elevated incidence rates.
Limitations and the Path to Validation
The current model has undergone internal validation only. External cohorts from different geographic and dietary contexts will be essential to confirm generalisability. Microbial communities vary with diet, oral hygiene practices, antibiotic exposure and environmental factors, meaning a signature effective in Johannesburg may require adjustment elsewhere.
Researchers also note that bacterial changes could represent a consequence of disease progression rather than a driver. Distinguishing these possibilities will require longitudinal sampling and comparison with individuals experiencing non-malignant swallowing difficulties.
Next Steps in Expanding the Research Programme
Plans call for enrolment of additional participant groups, including patients with benign oesophageal conditions and population-based controls. Integration of tumour mutation signatures with microbiome data may further illuminate environmental exposures that leave molecular fingerprints. Broader collaboration across epidemiology, genomics and environmental science is expected to refine understanding of why certain communities experience disproportionate rates.
Global and Regional Burden of Oesophageal Cancer
Worldwide, oesophageal cancer contributes substantially to cancer mortality, with more than 600,000 new diagnoses and over 540,000 deaths recorded in 2020 alone. Sub-Saharan Africa bears a notable share of this burden, particularly the squamous cell subtype. Improved early-detection strategies could meaningfully alter survival trajectories in settings where palliative care currently predominates.
Expert Perspectives on Microbiome Research in Oncology
Leading voices in the field recognise the promise of non-invasive microbial biomarkers while stressing the need for rigorous validation. Professor Christopher Mathew, a distinguished researcher at the institute, highlights the importance of combining microbiome insights with genetic susceptibility studies to build a comprehensive picture of disease causation and progression.
Implications for South African Public Health and Future Outlook
Successful development of a saliva-based triage approach could integrate into existing community health programmes, supporting earlier intervention in high-incidence areas. Continued investment in local research capacity will be vital to ensure that solutions are tailored to South African populations and ultimately reduce disparities in cancer outcomes.
The study represents an important milestone in applying cutting-edge molecular tools to a long-standing public-health challenge. As validation proceeds, the work may contribute to a new generation of accessible diagnostic aids that improve quality of life for patients and families across the region.